Zymosense

company

About

Zymosense develops novel probes for onsite and throughput enzyme measurement.

  • 1 - 10

Details

Last Funding Type
Grant
Industries
Biotechnology
Founded date
Jan 1, 2021
Number Of Employee
1 - 10
Operating Status
Active

Zymosense provides automated aqueous two-phase extraction for low-cost and scalable sorting of chiral-pure single-walled carbon nanotubes and a proof-of-concept demonstration for automating the NIST-developed ATP system for separating chiral-pure single-walled carbon nanotubes, enabling different industries to get access to rapid evaluation, discovery, and design of new enzymes.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$256K
Zymosense has raised a total of $256K in funding over 2 rounds. Their latest funding was raised on Jun 29, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 29, 2022 Grant 1 Iowa G2M Accelerator Detail
Nov 26, 2021 Grant $256K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Zymosense is funded by 2 investors. Iowa G2M Accelerator and National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
Iowa G2M Accelerator Yes Grant
National Science Foundation Yes Grant